Schizophrenia News and Research

Latest Schizophrenia News and Research

Roundup: N.D. abortion clinic sues to stop new law; Health care savings close budget hole in Conn.; Calif. counties struggle to expand mental health care

The running battle over the regulation of abortions entered a North Dakota courtroom on Wednesday, as the state's sole abortion clinic sued to block a new law that it says could force it to shut down. The law, requiring doctors performing abortions to have admitting privileges at a nearby hospital, was promoted by anti-abortion legislators, who argued that it would mean better care for women who suffer medical emergencies (Eckholm, 5/15).

17 May 2013

New research shows dysfunctional mitochondria in brain cells can lead to learning disabilities

Neuroscientist Patrik Verstreken of VIB (Flanders Institute for Biotechnology) and KU Leuven has shown for the first time that dysfunctional mitochondria in brain cells can lead to learning disabilities.

17 May 2013

Study provides new evidence that genetic risk for schizophrenia associated with lower IQ

The relationship between the heritable risk for schizophrenia and low intelligence has not been clear. Schizophrenia is commonly associated with cognitive impairments that may cause functional disability. There are clues that reduced IQ may be linked to the risk for developing schizophrenia.

17 May 2013

Viewpoints: Angelina Jolie on her decision to have a double mastectomy; Justice Ginsburg's 'blind spot' on abortion

My doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer, although the risk is different in the case of each woman. Only a fraction of breast cancers result from an inherited gene mutation. Those with a defect in BRCA1 have a 65 percent risk of getting it, on average. Once I knew that this was my reality, I decided to be proactive and to minimize the risk as much I could. I made a decision to have a preventive double mastectomy. I started with the breasts, as my risk of breast cancer is higher than my risk of ovarian cancer, and the surgery is more complex (Angelina Jolie, 5/14).

15 May 2013

Prenatal exposure to influenza increases risk of bipolar disorder in offspring

Pregnant mothers' exposure to the flu was associated with a nearly fourfold increased risk that their child would develop bipolar disorder in adulthood, in a study funded by the National Institutes of Health.

15 May 2013

Study provides evidence of altered circadian gene rhythms in brain tissue of people with depression

UC Irvine Health researchers have helped discover that genes controlling circadian clock rhythms are profoundly altered in the brains of people with severe depression.

14 May 2013

NAPHS releases new study that examines readmission patterns within Medicare IPF PPS

The National Association of Psychiatric Health Systems today released a new study by The Moran Company that is the first to examine readmission patterns within inpatient psychiatric facilities paid under the Medicare IPF prospective payment system.

13 May 2013

Missing link between over-stimulation and destruction of brain tissue identified

In many neurodegenerative diseases the neurons of the brain are over-stimulated and this leads to their destruction. After many failed attempts and much scepticism this process was finally shown last year to be a possible basis for treatment in some patients with stroke. But very few targets for drugs to block this process are known.

9 May 2013

Brain scan studies may provide clues about how the device improves depression

For nearly a decade, doctors have used an implanted electronic stimulator to treat severe depression in people who don't respond to standard antidepressant therapy.

8 May 2013

Targacept reports net loss of $8.1 million in first quarter 2013

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today reported its financial results for the first quarter ended March 31, 2013.

7 May 2013

Discovery may lead to new treatment for neurodevelopmental, neurodegenerative disorders

A key type of human brain cell developed in the laboratory grows seamlessly when transplanted into the brains of mice, UC San Francisco researchers have discovered, raising hope that these cells might one day be used to treat people with Parkinson's disease, epilepsy, and possibly even Alzheimer's disease, as well as and complications of spinal cord injury such as chronic pain and spasticity.

5 May 2013

Study results support new view of molecules important for nerve cell signaling

National Institutes of Health researchers used the popular anti-wrinkle agent Botox to discover a new and important role for a group of molecules that nerve cells use to quickly send messages.

3 May 2013

CHOP research offers insights into epilepsy, schizophrenia, other neuropsych disorders

Medical researchers have manipulated human stem cells into producing types of brain cells known to play important roles in neurodevelopmental disorders such as epilepsy, schizophrenia and autism.

3 May 2013

Schizophrenia cardiovascular risk under-recognized in primary care

UK researchers have found that despite being a major contributor to premature deaths among patients with schizophrenia, cardiovascular disease is less likely to be recorded on their primary care records than those of people without schizophrenia.

30 Apr 2013

UCLA study shows individuals with BDD have global bad wiring in their brains

Body dysmorphic disorder is a disabling but often misunderstood psychiatric condition in which people perceive themselves to be disfigured and ugly, even though they look normal to others. New research at UCLA shows that these individuals have abnormalities in the underlying connections in their brains.

30 Apr 2013

Neurons in the nose could be the key to early diagnosis of schizophrenia, says researcher

A debilitating mental illness, schizophrenia can be difficult to diagnose. Because physiological evidence confirming the disease can only be gathered from the brain during an autopsy, mental health professionals have had to rely on a battery of psychological evaluations to diagnose their patients.

30 Apr 2013

Delayed psychosis treatment harms chance of success

The longer patients with first-episode psychosis go untreated, the less likely they are to achieve remission within a year of starting treatment, report researchers.

29 Apr 2013

BioLineRx starts enrollment in Phase I/II trial of BL-8020 for treatment of HCV

BioLineRx, a biopharmaceutical development company, announced today enrollment of the first patient in a Phase I/II trial for BL-8020, an orally available, interferon-free treatment for the Hepatitis C virus.

29 Apr 2013

Testosterone’s role in schizophrenia

Researchers from Neuroscience Research Australia (NeuRA) have presented new results about the role of testosterone in schizophrenia at the International Congress on Schizophrenia Research being held in Orlando, Florida.

26 Apr 2013

New methods boost researchers' analytical powers by incorporating prior knowledge about SNPs function

As scientists probe and parse the genetic bases of what makes a human a human (or one human different from another), and vigorously push for greater use of whole genome sequencing, they find themselves increasingly threatened by the unthinkable: Too much data to make full sense of.

26 Apr 2013

Schizophrenia News and Research

Latest Schizophrenia News and Research

Roundup: N.D. abortion clinic sues to stop new law; Health care savings close budget hole in Conn.; Calif. counties struggle to expand mental health care

New research shows dysfunctional mitochondria in brain cells can lead to learning disabilities

Study provides new evidence that genetic risk for schizophrenia associated with lower IQ

Viewpoints: Angelina Jolie on her decision to have a double mastectomy; Justice Ginsburg's 'blind spot' on abortion

Prenatal exposure to influenza increases risk of bipolar disorder in offspring

Study provides evidence of altered circadian gene rhythms in brain tissue of people with depression

NAPHS releases new study that examines readmission patterns within Medicare IPF PPS

Missing link between over-stimulation and destruction of brain tissue identified

Brain scan studies may provide clues about how the device improves depression

Targacept reports net loss of $8.1 million in first quarter 2013

Discovery may lead to new treatment for neurodevelopmental, neurodegenerative disorders

Study results support new view of molecules important for nerve cell signaling

CHOP research offers insights into epilepsy, schizophrenia, other neuropsych disorders

Schizophrenia cardiovascular risk under-recognized in primary care

UCLA study shows individuals with BDD have global bad wiring in their brains

Neurons in the nose could be the key to early diagnosis of schizophrenia, says researcher

Delayed psychosis treatment harms chance of success

BioLineRx starts enrollment in Phase I/II trial of BL-8020 for treatment of HCV

Testosterone’s role in schizophrenia

New methods boost researchers' analytical powers by incorporating prior knowledge about SNPs function

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Schizophrenia News and Research

Latest Schizophrenia News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in